indazoles has been researched along with Cancer of Larynx in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ji, Y; Li, L; Sun, G; Wang, Q; Ye, L; Zhao, Q; Zhao, S | 1 |
| Chang, HW; Cho, KJ; Choi, SH; Kim, GC; Kim, SY; Lee, SW; Moon, SY; Nam, SY; Roh, JL | 1 |
2 other study(ies) available for indazoles and Cancer of Larynx
| Article | Year |
|---|---|
Autophagy suppression enhances DNA damage and cell death upon treatment with PARP inhibitor Niraparib in laryngeal squamous cell carcinoma.
Topics: Autophagic Cell Death; Cell Cycle; Cell Line, Tumor; DNA Damage; Humans; Indazoles; Laryngeal Neoplasms; Piperidines; Poly(ADP-ribose) Polymerase Inhibitors | 2019 |
Using YC-1 to overcome the radioresistance of hypoxic cancer cells.
Topics: Carcinoma, Squamous Cell; Cell Hypoxia; Cell Line, Tumor; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; In Vitro Techniques; Indazoles; Laryngeal Neoplasms; Radiation Tolerance; Radiation-Sensitizing Agents; Treatment Outcome | 2009 |